Back

NATURE-PCSK9 trial

29 August 2021 (10:30 - 10:45)
Organised by:
Congress Presentation Part of: Late Breaking Science in Prevention Drug therapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Fixed Dose Combination Therapies with or without Aspirin in Primary Prevention of Cardiovascular Disease
Doctor P. Joseph (Hamilton, CA)
Slides Video
Presentation thumbnail
Explanations for contrasting results of REDUCE-IT vs. STRENGTH
Doctor T. Doi (Herlev, DK)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Prevention
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Effect of PCSK9 inhibitors on coronary plaque: a meta-analysis and trial sequential analysis
1 September 2025
thumbnail
Congress Presentation
LIBerate-HeFH - a novel PCSK9-inhibitor in heterozygous FH
28 August 2023
thumbnail
Congress Presentation
A randomized, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome: PALISADE - 1 year open label extension
30 August 2025
thumbnail
Congress Presentation
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources